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1 Short Summary  
 
In drug research, growing scientific and regulatory demands increase the need for novel analytical 
methods. Especially in skin drug delivery research, advanced analytical techniques are urgently 
needed. The ability of contactless, label-free and chemically selective detection and quantification of 
substances predestines confocal Raman microscopy to fill this scientific gap. 
In this work, we implement confocal Raman microscopy in skin drug delivery research regarding 
reevaluation of existing in vitro approaches and acquisition of quantitative substance depth profiles in 
skin tissue. At first, we use Raman imaging to verify the suitability of porcine ears as in vitro model for 
follicular uptake. Furthermore, we investigate Raman signal attenuation as major drawback for 
quantitative depth profiling via the development of an artificial skin surrogate and evaluate the 
variability of Raman data acquired from different human skin donors. Moreover, we perform a 
systematic proof-of-concept study highlighting the possibility of quantitative depth profiling inside 
skin. Finally, we present freeze-drying as customized sample preparation technique to simplify and 
standardize quantitative depth profiling. 
Overall, the key parameters necessary for a standardized implementation of confocal Raman 
microscopy are understood and we elucidate crucial interdependences. This newly gained knowledge 
will help to advance current analytics in skin drug delivery research beyond the state-of-the-art. 
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2 Kurzzusammenfassung 
 
In der Arzneimittelforschung steigern wachsende wissenschaftliche und regulatorische 
Anforderungen den Bedarf nach neuen analytischen Methoden. Besonders in der dermalen Galenik 
sind die Ansprüche an die Analytik gestiegen. Durch die Fähigkeit zur kontaktfreien und chemisch 
selektiven Detektion und Quantifizierung von Substanzen hat konfokale Raman Mikroskopie das 
Potenzial diese Anforderungen zu erfüllen. 
In dieser Arbeit implementieren wir Raman Mikroskopie für die Neubewertung existierender in vitro 
Methoden und die Aufnahme quantitativer Tiefenprofile in Haut. Wir nutzen bildgebende Raman 
Mikroskopie um die Eignung von Schweineohren als in vitro Modell für follikulare Aufnahme zu 
bestätigen. Zudem bestimmen wir Raman-Signaldämpfung, das Haupthindernis bei der Erfassung von 
quantitativen Tiefenprofilen und bewerten die Variabilität von Raman-Spektren verschiedener 
menschlicher Hautproben. Ebenso zeigen wir in einer systematischen Machbarkeitsstudie erste 
quantitative Raman-Messungen in Haut und stellen Gefriertrocknung als maßgeschneiderte 
Probenaufbereitung für die vereinfachte und standardisierte Erfassung quantitativer Tiefenprofile vor. 
Insgesamt werden die entscheidenden Parameter für eine standardisierte Anwendung von Raman 
Mikroskopie verstanden und wichtige Zusammenhänge aufgeklärt. Auf dieser Grundlage kann sich 
konfokale Raman Mikroskopie durch weiter vereinfachte Messroutinen und spezialisierte Instrumente 
zu einer Standardmethode in der dermalen Arzneimittelforschung weiterentwickeln. 
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3 Introduction 
 
3.1 State-of-the-art in skin drug delivery research 
The human skin comprises one of the largest organs in the human body. With an estimated area of 2 
m², skin represents the main barrier between an organism and its environment. Today, the human 
skin faces the challenge of constant exposure to chemical, physical and biological hazards. Besides 
forming the first line of defense of the immune system, skin also regulates the water content of the 
human body and functions as heat insulation. This results in a sophisticated need to balance 
permeability and impermeability. To fulfill this complex task, skin exhibits a layered structure with 
individual composition. The skin’s outside is covered with a hydrolipid film consisting of fatty acids and 
amino acids providing a low pH environment as antimicrobial feature. The main barrier function is 
constituted by the stratum corneum as the outermost skin layer. This layered structure is 10 µm – 40 
µm thick in the areas relevant for percutaneous absorption like abdomen, upper arm and neck (1). 
The stratum corneum consists of cornified cells embedded in a coherent lipid matrix in a ‘brick and 
mortar’ like structure (2), which impedes substance penetration. The dead corneocytes are 
surrounded by a lipid layer consisting of ceramides, fatty acids and cholesterol derivatives (3). Most 
skin absorption studies focus on the stratum corneum as the main limiter for substance penetration 
and permeation. The cornified cells derive from the living epidermis located beneath and are bordered 
by the basal membrane. Appendices like sweat glands and hair follicles are located in the adjoining 
dermis. The complex assembly and versatile function of the skin is reflected in a diverse field of skin 
related research ranging from cosmetics to drug delivery. With the advantage of avoiding the first pass 
effect, the painless and non-invasive administration of drugs via the skin is a convenient alternative to 
parenteral or oral drug application. Furthermore, the easy access to most skin areas facilitates local 
application of drugs for fast and targeted treatment of the skin and the tissues below. However, 
overcoming the skin barrier is a challenging task for skin drug delivery research. Therefore, effective 
skin research demands extended knowledge of substance penetration and permeation behavior. 
Especially for development and optimization of skin therapeutics, a suitable analytical setup is an 
essential prerequisite (4).  
Since in vivo testing is expensive and subject to strict obligations, in vitro studies are a mandatory 
requisite in formulation development. Accessing rate and extent of substance penetration into the 
skin in vitro is commonly performed by tape stripping and extraction. After topical substance 
application to the skin sample, adhesive tape is used to remove the stratum corneum layer by layer. 
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Subsequently, the substance of interest is extracted from each tape and quantified. Further tissue 
segmentation by micro-cryotome gives additional information on substance penetration behavior into 
the deeper skin layers including viable epidermis and dermis (5). Despite recent approaches an exact 
determination of sample depth remains a challenge during the tape stripping procedure, since the 
removed layer thickness is mostly indistinct (6). In vitro permeation through the skin is accessed by 
the Franz diffusion cell as the most common setup. The cell comprises a skin layer separating a donor 
and an acceptor compartment. By analyzing the substance concentration in the acceptor 
compartment, the permeated amount can be quantified (7). These techniques demand a great deal 
of manual work by a skilled and trained experimenter. A reliable automated measurement system 
with defined spatial resolution would speed up and standardize analysis and improve the 
transferability of acquired results. Furthermore, state-of-the-art penetration and permeation testing 
is destructive and requires large amounts of sample material. In the light of limited availability of 
excised human skin and ethical restrains on the use of animal skin, a reduction of sample size and 
number is advantageous. Thus, there is a strong demand for novel non-destructive techniques 
reducing sample size and an instrumental implementation for automated measurements.  
In this context, optical methods such as fluorescence microscopy, infrared and Raman spectroscopy 
provide the advantages to fill these scientific gaps. The contact-free measurement mode and 
immediate analytical readout led to first implementations of optical techniques in skin research. 
Starting in the late 90s, several optical techniques have been applied to study skin pathophysiology as 
well as for permeation and penetration studies (8, 9). Recently, microscopy based optical methods like 
confocal laser scanning microscopy (CLSM) and multiphoton microscopy (MPM) have been used to 
track substances upon penetration into skin in vivo and in vitro. CLSM and MPM provide spatially 
resolved information on substance penetration depth and molecular interaction between substance 
and skin (10-12). Both techniques require fluorescent signals from the substances of interest, which is 
mostly achieved by labelling. However, the used dye or fluorescent label can interfere with a strong 
autofluorescence emitted by the skin itself, mostly caused by melanin and collagen. In addition, the 
use of a label might introduce alterations to substance penetration behavior and transferability of the 
results is impaired. In contrast, vibrational spectroscopy provides direct molecular information 
without labelling. Infrared spectroscopy (IR), as a well-established technique in vibrational 
spectroscopy, is based on the absorption of light. In skin drug delivery research, IR has successfully 
been applied in vivo and in vitro for physiological investigations and follow-up of penetrating 
substances (13-16). However, the accuracy of IR measurements is limited to 5-10 µm and the 
asymmetric OH vibration of water interferes with signals from many chemical substances. This 
impedes spatially high resolved measurements in hydrated biological tissue. Raman spectroscopy as 
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complementary vibrational spectroscopic technique provides chemically selective information about 
the sample composition similar to IR. In contrast to IR, Raman spectroscopy provides a spatial 
resolution below 1 µm in a confocal setup and is not interfered by strong water signals, bearing the 
potential for data acquisition inside skin. 
 
3.2 From the Raman effect to a new analytical technique  
The effect of Raman scattering was first reported in 1928 by the Indian physicist Sir C.V. Raman, who 
later was awarded the Nobel prize in physics for this discovery (17). When light interacts with matter, 
the effect of light scattering is the most infrequent among other phenomena like transmission and 
absorption. Scattering only occurs when photons and matter collide on atomic scale. In case of an 
elastic collision, the energy amounts of incoming and outgoing photons remain unchanged. This type 
of scattering is called Rayleigh scattering. A different effect reported by C.V. Raman occurs in case of 
inelastic collisions between incoming photons and dense electron systems like molecular functional 
groups. If the scattered photons loose energy compared to the incident photons, it is called Stokes 
scattering. In the rare case of higher energy levels in the outgoing photons, the effect is described as 
anti-Stokes scattering. Both, Stokes and anti-Stokes effects can be detected by monitoring the 
frequency and therefore the energy content of the scattered photons. Stokes scattering is detected at 
lower frequency (lower energy) and anti-Stokes scattering at higher frequency (higher energy) 
compared to the incoming photons. A schematic drawing of the energy levels of incoming and 
outgoing photons for the different scattering effects is depicted in figure 1 A. Because of the rare 
occurrence of anti-Stokes scattering, conventional Raman spectroscopy utilizes only Stokes scattering. 
In Raman spectroscopy, the energy shift of the scattered photons is measured against their quantity 
of occurrence. Therefore, a Raman spectrum is depicted as energy shift in wavenumbers on the x-axis 
and scattering intensity as dependent value, having the advantage that the correlation of 
wavenumber, frequency and energy content is linear. The energy amount onto which the photons are 
shifted after light matter interaction is characteristic for molecular vibrations representing specific 
molecular functional groups. The Raman scattering pattern is specific for a chemical structure and 
resembles a ‘molecular fingerprint’. Furthermore, the count of scattered photons at a defined Raman 
shift and therefore the signal intensity correlates linear with the quantity of the represented molecule. 
This enables a linear correlation between Raman signal intensity and substance concentration. Thus, 
Raman spectroscopy allows chemically selective identification and quantification without any 
labelling. The described scattering process is provoked by large delocalized electron systems, resulting 
in strong Raman bands from non-polar functional groups and aromatic structures. Most small 
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molecule drugs involve aromatic structures and are strong Raman scatterer and therefore easy to 
monitor. Biological tissues such as skin have a high variability in chemical composition (18). The 
resulting large number of different functional groups leads to a highly complex Raman pattern with 
weak characteristics and strong background signals. As only 1 in 107 scattered photons is relevant for 
the Raman effect, high detector efficiency and sophisticated optical engineering were necessary to 
make Raman spectroscopy interesting for skin research.  
 
 
 
Figure 1: A Energy level diagram illustrating different types of scattering, line thickness corresponds 
with the probability of appearance. B Schematic of a confocal Raman microscopic setup, red lines 
indicate the way of excitation laser light and gathered Raman scattering. Reproduced with permission 
from (19). 
 
In the course of the necessary advancement, Raman spectroscopy was implemented in other optical 
instruments like fiber probes and microscopes (20, 21). The combination of Raman spectroscopy and 
confocal microscopy allows the compilation of spatially resolved Raman information. Confocal Raman 
microscopy (CRM) usually includes a laser source and a spectrometer as detection unit built in a 
confocal microscope. The laser beam is focused through the microscope objective, allowing the light 
to interact with the sample on the microscope stage. The scattered photons are collected through the 
objective and directed towards the detection unit by optical fibers. Cameras equipped with charge 
coupled devices detect the scattered photons and visualize the energy pattern as Raman spectrum. A 
confocal pinhole rejects photons from out of focus planes, limiting the gain of spectral information to 
one voxel. This volumetric pixel, where the Raman information is acquired can freely be moved in all 
three dimensions by an automated sample positioner. A schematic of a typical confocal Raman 
microscope is illustrated in figure 1 B. The localized and reproducible acquisition of Raman spectra 
enables a broad panel of measurement modes. A single Raman spectrum provides chemical 
information on the sample composition in one exact spot. A combination of subsequently acquired 
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Raman spectra allows insight in changes in chemical composition as a function of spatial position. In a 
one directional assembly, Raman spectra can be collected along a line. With this line going into the 
sample, a series of Raman spectra can be collected in different depths beneath the sample surface. 
These depth profiles display relative or absolute changes in specified peak intensities over depth. Two 
dimensional series of data acquisition can be transformed into spectral maps. Single spectra are 
collected step by step in a defined plane (x-y or y-z) and the spectral information from each pixel is 
converted into false color images. These false color images are an important visualization tool for 
sample composition and component distribution. Three dimensional measurements include the 
assembly of multiple maps to a picture stack. This measurement mode is time consuming and requires 
advanced data processing. A summary of the different measurement modes and data evaluation 
methods is presented in figure 2. 
Virtual three dimensional measurements can be achieved by combining CRM with optical 
profilometry. In optical profilometry, a white light source and an assembly of lenses with high 
chromatic aberration are used to acquire a surface map of an opaque sample. The measurement 
principle is based on white light reflectance and the wavelength of the detected light can be correlated 
to the specific distance between light source and sample surface. Based on this information, the 
software focusses the laser on the exact surface of the sample without the necessity of manual 
focusing (22).  
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Figure 2: A Depth profiling: Raman spectra are recorded along a z-directed line, peak intensities are 
depicted as intensity profiles against depth. B y-z intensity mapping: in y-z direction acquired Raman 
spectra are presented by color coded peak intensities in a two dimensional picture creating a virtual 
cross section. C z-stack false color imaging: series of x-y maps are stacked to a three dimensional data 
set, different components are assigned to different colors. Reproduced with permission from (19). 
 
In confocal Raman microscopic imaging, the laser spot size defines the spatial resolution. Derived from 
the point spread function, lateral resolution (LR) can be estimated as LR = 0.82λ/NA (NA = numerical 
aperture of the objective). The axial resolution (AR) is impacted by the refractive index of the 
immersion medium (n): AR = 2.2nλ/π(NA)² (23). In state-of-the-art Raman microscopes, resolution can 
be down to about 200 nm in lateral and about 500 nm in axial direction. For depth profiling of excised 
human skin, an ideal penetration depth has been reported for an excitation wavelength of 785 nm 
and the usage of air interface objectives is necessary to avoid interactions of the sample with the 
immersion medium (24). After recording of Raman spectra, further data processing becomes 
necessary. However, most measurement software automates the removal of cosmic ray related peaks. 
For quantitative evaluation, adjusting the spectral baseline is required. For biological samples, a 
polynomic fitting functions describes the baseline and facilitates further data processing (25, 26). 
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3.3 Confocal Raman microscopy in skin research – potential and challenges 
As a first application of CRM in dermal research, initial studies focused on the physiological 
investigation of the skin. As pioneers, the group of Puppels et al. established CRM to access the skin 
hydration status in the late 90s (27, 28). For implementing CRM in skin drug delivery research, analysis 
and evaluation of in vitro skin models is a primary objective. Besides previously investigated animal 
skin models like shed snake skin (29, 30), porcine skin represents the most commonly applied skin 
model for in vitro testing. Some studies already focused on the physiological evaluation of porcine skin 
by CRM (31, 32). Tfaili et al. concluded a general comparability of human and porcine skin regarding 
its spectral features (33). Although human skin is still generally considered as gold standard for 
penetration and permeation experiments, porcine ear skin is considered superior for testing of 
follicular uptake (34, 35). The transfollicular route for administration of drugs recently came in the 
center of attention, especially since it has been shown that nanoparticle based drug delivery systems 
facilitate uptake into hair follicles and act as drug reservoir (36, 37). In addition, the presence of 
immune cells bears the potential for trans-follicular vaccination (38). In contrast to excised human 
skin, porcine ear cartilage prevents the closure of hair follicles after excision allowing particle uptake 
close to the in vivo situation. However, it is important to know to which extent porcine and human 
hair follicles are comparable. Anatomically both comprise an invagination of epidermis, an inner and 
outer root sheath and sebaceous glands connected to the follicle (39). To compare the composition 
of human and porcine hair follicles on a chemically selective level, CRM provides the possibility of 
label-free localization and characterization of the main components (40). Special focus is required on 
the sebum’s composition, since it might influence release behavior and depot sustainability of applied 
drug delivery systems (41). 
Although porcine skin has proven beneficial for testing of follicular penetration, excised human skin is 
the most suitable model for in vitro penetration experiments (42). While previous studies utilized skin 
obtained from cadavers, human skin removed during plastic surgery is considered the gold-standard 
skin sample (42). To assure transferability of results obtained from excised human skin, most 
laboratories limit the usage to abdominal skin samples from healthy female volunteers. Nevertheless, 
skin remains a highly complex tissue with variable composition (43). Results of penetration studies 
obtained from different skin donors by tape stripping are known to exhibit high variability (44). The 
use of a standardized and automated analytical technique like CRM might prove beneficial regarding 
reduced result variability and increased transferability. However, it has been reported that recorded 
Raman spectra reflect the high variability of skin composition in vivo (45). To implement CRM in the 
field of penetration studies, the variability of the obtained spectra has to be evaluated towards 
Introduction 
 
 
- 14 - 
reliability and transferability of obtained results. Furthermore, it is necessary to differentiate between 
the disagreement of multiple measurements on one sample and the disagreement in spectral 
information obtained from different donors to comprehensively evaluate spectral variability. The 
proof of transferability of the obtained results is an essential prerequisite for drug detection and 
quantification inside the human skin samples in vitro. 
The use of CRM to analyze substance penetration behavior is the most worthwhile and most 
demanding application for CRM in skin research. It has been shown that CRM is capable of following 
a substance in relation to other substances by relative spectral depth profiling. While Forster et al. 
focused on the tracking of cosmetic relevant compounds (46), and Broding et al. followed chemicals 
for risk assessment (47), others adapted the method for pharmaceutical research (47-50). The lab of 
Mendelsohn succeeded in monitoring the ratio between drug and prodrug during skin penetration 
(51, 52). However, to compete with state-of-the-art analytical techniques, quantification of the 
penetrating substance is vital. The fact, that the acquired Raman signal intensity is linear to the 
substance concentration, enables quantitative CRM measurements as previously shown (53). 
However, transferring this potential to the complex situation of measurements inside biological tissue 
is a challenging task. Drawbacks and pitfalls in depth profiling with confocal Raman spectroscopy have 
previously been summarized (54-56). Everall et al. highlight the uncertainty of depth determination 
during depth profiling. Mendelssohn et al. used layered polymer films to determine the depth 
uncertainty between 11-16% and Piot et al. evaluated various mathematical correction algorithms (57, 
58). The remaining major drawback to implement quantitative depth profiling is Raman signal 
attenuation. With ongoing depth the Raman signal loses intensity due to absorption, reflection and 
scattering effects inside the sample. This loss of intensity inside a sample causes the loss of the linear 
correlation between signal intensity and substance concentration. The effect of signal attenuation on 
spectral measurements is illustrated in figure 3. Knowledge about rate and extent of the signal 
attenuation under certain conditions is essential to perform quantitative Raman measurements 
beneath the sample surface. So far, Raman signal attenuation has been circumvented by relating the 
peak of the substance of interest to a skin representing Raman peak. This method premises that both 
peaks are affected by the Raman signal attenuation to similar extend. However, this requires the 
substance from which the peak is derived, to be constant throughout all layers and depths of the skin 
sample. An ultimate proof-of-concept that valid quantitative measurements by CRM in skin are 
possible by peak relation is still missing. This includes a systematic study that comprises a validation 
of quantitative data acquired by CRM against a standard quantification method and thorough 
evaluation and selection of peaks suitable as internal standards. 
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Figure 3: Schematic explanation of Raman signal attenuation. A Basic principle of depth profiling in 
skin. B Raman spectra recorded along the red line in A. C Intensity depth profile of a selected Raman 
peak highlighted in B. With ongoing depth, the Raman signal decays due to a reduced yield of collected 
photons. Reproduced with permission from (19). 
 
Besides these major challenges the implementation of confocal Raman microscopic depth profiles is 
impeded by other drawbacks. Although automated, CRM measurements are time consuming and the 
sample is constantly irradiated by laser light. This gives way to further diffusion of the penetrated 
substance, microbial growth and sample movement caused by thermal changes and drying effects. 
These new challenges follow the recent developments of CRM in skin depth profiling. In order to 
establish CRM as novel analytical tool, new ways of sample preparation and preservation are 
necessary specifically addressing the aforementioned issues. 
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4 Aims 
From the current state-of-the-art in skin research it becomes eminent that novel analytical strategies 
are needed to cope with the increasing requirements. Confocal Raman microscopy (CRM) already 
indicated its potential for versatile analytical implementation especially in skin drug delivery research. 
One of the most demanding and challenging applications in skin drug delivery research is the 
determination of substance concentration depth profiles. Obtaining information about rate and 
extent of substance penetration into skin is of major importance to evaluate and optimize drug 
delivery as well as to assess health risks of chemicals. Determining the concentration of the respective 
substance in a defined depth is currently performed by a labor-intensive sequence of removal and 
extraction of different skin layers. The ability of CRM to acquire chemical information from inside a 
sample bares the potential to localize and quantify a substance in skin. The advantages of utilizing 
CRM for substance depth profiling include a label-free, non-destructive and automated mode of 
operation. Different groups around the world already leaped forward and employed CRM in 
conventional analytical setups. However, to master the existing challenges rethinking of conventional 
approaches and redesigning of standard procedures is necessary. The overall goal of this thesis is to 
fully exploit the benefits of CRM in skin drug delivery research and establish CRM as standardized 
analytical method for quantitative drug depth profiling in vitro. To achieve this goal, we state four 
major aims: 
 
I. To solve existing problems and eliminate uncertainties with the novel insights offered by CRM 
II. To understand and overcome current limitations for substance depth profiling in skin 
III. To establish CRM as tool for quantitative depth profiling 
IV. To simplify and standardize CRM measurements 
 
The first aim includes the reevaluation of existing approaches for skin penetration analysis. CRM can 
provide new insights in current methods and eliminate existing doubts. Especially sophisticated in vitro 
models still lack a proof of validity and CRM can vindicate their application.  
The second aim focusses on CRM for substance depth profiling. Gathering detailed spectral 
information from inside a skin sample is impeded by numerous factors. Previous studies already 
identified Raman signal attenuation as major drawback. When light enters a non-transparent medium 
like skin, the signal intensity is reduced. In Raman spectroscopy, this reduced signal causes a loss of 
the linear correlation between signal intensity and substance concentration. Furthermore, the high 
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variability of in vitro skin samples in composition and penetration behavior is well known. A significant 
impact on Raman spectroscopic investigations is expected.  To understand and rate the impact of such 
factors on CRM measurements is a mandatory prerequisite for further developments. 
The third aim comprises the quantification of substances as exploitation of the full potential of CRM 
for substance depth profiling. The linear correlation between Raman signal intensity and substance 
concentration theoretically enables the acquisition of quantitative concentration depth profiles in 
skin. The understanding of aforementioned limitations should enable the implementation of 
quantitative measurement routines. The possibility to acquire concentration depth profiles contact-
less and label-free in in vitro skin samples would be an important advancement of current analytics. 
Finally, the fourth aim pursues the implementation of quantitative depth profiling in a novel simplified 
and standardizable analytical setup. It is expected that the usage of conventional preparation of 
human skin samples for CRM in vitro depth profiling introduces a number of unwanted drawbacks in 
sample behavior and measurement inaccuracies. To facilitate the implementation and to increase the 
transferability of results, customized approaches from sample preparation to data evaluation are 
needed.  
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5 Scientific Outcome 
 
5.1 Advanced chemical imaging and comparison of human and porcine hair follicles 
for drug delivery by confocal Raman microscopy 
 
 
This chapter refers to: 
 
L. Franzen*, C. Mathes*, S. Hansen, M. Windbergs, ‘Advanced chemical imaging and comparison of 
human and porcine hair follicles for drug delivery by confocal Raman microscopy’, J Biomed Opt, 18 
(2013) 61210 
*both authors contributed equally to this work 
 
 
As novel approach for drug administration, the transfollicular route has recently gained a lot of 
attention. The reported increase in penetration rate of nano-sized drug delivery systems and a 
potential reservoir formation led to numerous novel applications (36, 59, 60). As an invagination of 
the epidermis, a hair follicle provides high surface area with numerous blood vessels and antigen 
presenting cells in the adjoining tissue. This facilitates drug uptake und bares the potential for a 
triggered immune response (38). To develop new drug delivery systems tailored for the transfollicular 
route, a suitable in vitro model is necessary. Unfortunately, excised human skin, as gold-standard 
model for in vitro penetration and absorption, was found to be unfavorable for this task. A contraction 
of tensile fibers subsequent to the excision closes the follicle and impedes the uptake of an applied 
formulation. In contrast to human skin, the skin of a porcine ear is fixed on the cartilage, which 
prevents the follicle from closing. In combination with comparable results in penetration and 
absorption studies and a broad availability from abattoir refuse, without ethical concerns, porcine ear 
skin comprises the preferred in vitro model for follicular absorption studies (34). To quantify the extent 
of follicular penetration, cyanoacrylate skin surface stripping is performed. After application of 
superglue to a skin area, corneocytes, the stratum corneum and the follicular cast are stripped off 
(61). 
With the introduction of this new analytical setup, the question of comparability of human and porcine 
follicles arises. Furthermore, a complete removal of the hair follicle by cyanoacrylate biopsies has to 
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be assured for reliable quantification. In this scientific gap, confocal Raman microscopy can prove its 
versatile values for skin drug delivery research due to its previously discussed features. 
At first, we used Raman microscopy to analyze the chemical composition of a sample in a defined 
location. Despite an apparent anatomical similarity depicted in histological cross sections in figure 4 A 
and B, a chemical equivalence is important to mimic the simulated body side in humans. Especially the 
sebum as potential release medium for an applied drug delivery system needs to be considered. The 
targeted acquisition of Raman spectra from the four major components of a hair follicle allowed the 
comparison of the chemical composition of respective components. The spectra are presented in 
figure 4 C and D. A detailed analysis, including spectral subtraction revealed little to no difference in 
the Raman spectra of human and porcine, epidermis, dermis and hair. In sebum a slight discrepancy 
in the wavenumber range of 1050 cm-1 and 1090 cm-1 indicated conformational differences between 
the lipids in human and porcine sebum (62). Overall, these results prove a general comparability of 
human and porcine hair follicles and indicate the suitability of porcine ears as in vitro model.  
 
Figure 4: Microscopic pictures of porcine A and human B hair follicle cross sections. Raman spectra 
obtained from the areas marked by the colored crosses displayed in corresponding colors from porcine 
C and human D follicles. Reproduced with permission from (63). 
Furthermore, we used Raman imaging to identify and localize the main components of a hair follicle 
in a histological cross section. Usually visualization of the different components is performed by 
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complex steps of different dyeing procedures. In contrast Raman microscopy classifies spectra by 
chemical similarity and delivers a false-color image depicting the different components in different 
colors. By combining CRM with an optical profilometer, we employed Raman imaging to visualize a 
follicular cast after removal by cyanoacrylate biopsy. Figure 5 D reveals an intact epidermis shell 
around the removed follicle. Therefore, a complete extraction of the formulation can be assumed and 
the suitability of differential stripping to quantify penetrated drug and delivery system is confirmed.  
 
 
 
Figure 5: A Light microscopy picture of an excised hair follicle. B Surface topography map of the area 
indicated by the red rectangle in A. C Raman spectra of the individual chemical components in the hair 
follicle. D Raman map displaying the component distribution on the excised hair follicle. Reproduced 
with permission from (63). 
 
 
In conclusion, CRM was able to provide valuable insights in an existing in vitro model. By utilizing CRM 
remaining doubts were eliminated and the analytical course of action was approved. This versatile 
and complex application demonstrates the potential of CRM in skin drug delivery research. 
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5.2 Towards drug quantification in human skin with confocal Raman microscopy 
 
 
This chapter refers to: 
 
L. Franzen, D. Selzer, J.W. Fluhr, U.F. Schaefer, M. Windbergs, ‘Towards drug quantification in human 
skin with confocal Raman microscopy’, Eur J Pharm Biopharm, 84 (2013) 437-444 
 
 
Not only in skin drug delivery research but also for risk assessment of chemicals, the knowledge of 
rate and extent of substance penetration is highly important. However, the acquisition of substance 
depth profiles is one of the most challenging analytical procedures in skin research. In this context 
CRM is considered a promising option to advance analytics beyond the labor-intensive and destructive 
state-of-the-art. CRM has already been applied for first studies tackling penetration analysis in skin 
(28, 48, 49, 52). However, all previous studies limit themselves to relative depth profiling by comparing 
the penetration depth of two components. The lack of quantitative studies originates from Raman 
signal attenuation as main drawback. Upon penetration into the skin the exciting light is weakened by 
reflectance, absorbance, diffraction and other optical effects. This causes a decrease in scattered 
photons necessary for detection of the Raman effect. This imponderable attenuation of the signal 
leads to a loss of the linear correlation between signal intensity and substance concentration. In this 
chapter we present a first investigation focusing on Raman signal attenuation. Aim of this study was 
to gain insight knowledge and derive methods to circumvent Raman signal attenuation. 
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To deeply understand Raman signal attenuation, we developed a skin surrogate comprising the main 
components of human skin, similar in optical properties but homogenous in composition. In this 
homogeneous skin surrogate, we included keratin as main protein and a mixture of fatty acids, 
triglycerides and cholesterol.  After assuring similarity regarding spectral properties and refractive 
index, we acquired Raman depth profiles inside the surrogate. By absence of concentration gradients, 
the homogeneous mixture assures, that the decay in Raman signal is solely caused by signal 
attenuation. The measured Raman signal attenuation was fitted mathematically and exposed to be 
approximated by an exponential function. Figure 6 exhibits the mean Raman intensity depth profile 
from the skin surrogate and its mathematical fit as described in equation 1. 
 
 
 
Figure 6: Raman mean drug intensity depth profile based on three skin surrogates (solid line mean ± 
SD, n = 3) and fitting function (dashed line). Reproduced with permission from (64). 
 
 
  Equation 1 
 
 
This first mathematical description of Raman signal attenuation in our surrogate was confirmed by 
reevaluation of measurements made in excised human skin. The mathematical description of the 
signal attenuation was translated into a re-attenuation algorithm, which succeeded in eliminating the 
Raman signal attenuation from Raman depth profiles acquired in human skin. The original intensity 
depth profiles and the corrected profiles of a model drug in two human skin samples are depicted in 
figure 7 A and B.  
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Figure 7: A and B Raman mean intensity depth profile for caffeine in two skin donors (solid line, mean 
± SD, n = 3) and corrected profile (dashed line, mean ± SD, n = 3). Reproduced with permission from 
(64). 
 
To conclude, this study offers deeper understanding of the effect of Raman signal attenuation. In 
addition, we offer a mathematical way to cope with signal attenuation, serving as a first step to 
overcome this major drawback. 
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5.3 Accessing Raman spectral variability in human skin for quantitative depth 
profiling 
 
 
This chapter refers to: 
 
L. Franzen, M. Windbergs, ‘Accessing Raman spectral variability in human skin for quantitative depth 
profiling’, J Raman Spectrosc, 45 (2014) 82-88  
 
 
Besides the optical issue of Raman signal attenuation, the skin as target tissue exhibits some unique 
challenges. Due to ethical concerns and economic considerations in vivo screening of substance 
penetration is not suitable for many tasks. Hence, elaborate in vitro models are necessary for rational 
development of skin drug delivery systems. Excised human skin from plastic surgery presents the 
favored gold-standard model for in vitro penetration testing (42). However, excised human skin as 
primary biological tissue is known to exhibit a high variability in composition and structure (43) 
reflected in a complex Raman spectrum (45). The implementation of CRM as analytical tool for in vitro 
depth profiling in excised human skin might be affected by these variabilities and the obtained results 
could reflect the deviation. This can ultimately lead to a lack of comparability and transferability of 
stated findings obtained from different skin sources. Furthermore, one of the most common 
approaches to overcome Raman signal attenuation is to relate the Raman peak of the substance under 
investigation to a Raman peak derived from a skin component. This requires a certain Raman signal to 
be constant throughout all skin layers with a minimum of variation. Therefore, we discuss in this 
chapter the results of a systematic study targeting the variability of Raman spectra obtained from 
multiple skin donors.  
By detailed investigation of an averaged Raman spectrum of human stratum corneum, we identified 
four major spectral bands representing four major skin components as displayed in figure 8. First, 
marked in green, the C-C stretch vibrations represent the ring breathing of the aromatic amino acids 
phenylalanine and tyrosine, detectable in the wavenumber range 995-1018 cm-1. Second, the CH2 
deformation, mainly originating from alkyl chains in triglycerides and free fatty acids incorporates skin 
lipids. The wavenumber region for peak investigation was selected as 1288-1314 cm-1 and is 
highlighted in blue. As third peak, assigned in orange, the unspecific and therefore most intense C-H 
deformation in the wavenumber range 1388-1497 cm-1 was evaluated. C-H deformations can be found 
in lipids as well as in proteins throughout the skin. Fourth is the magenta labeled N-C=O stretch 
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vibration embodying amid I as found in proteins. This protein representing peak was defined as the 
wavenumber range of 1559-1721 cm-1. The above mentioned peaks are representative for the major 
skin components, the selected wavenumber areas were used for detailed investigation of Raman 
spectral variability of human skin. For potential quantification the relation of peak intensity and 
substance amount is of uttermost importance, therefore we focused our investigations on the 
integrated intensity of the selected wavenumber ranges.  
 
 
Figure 8: Raman spectrum of untreated human stratum corneum. Average of 27 spectra from three 
donors. The marked regions represent the four major peaks selected for further analysis. green: 
aromatic amino acids, blue: lipids, orange: lipids and proteins, magenta: proteins. Reproduced with 
permission from (65). 
 
One of the biggest concerns regarding the variability of Raman spectra of human skin includes the 
transferability of results obtained using skin from different donors. Due to limited amounts from one 
individual, often skin from multiple donors is utilized for a single study. By acquiring Raman spectra 
from different skin samples from different skin donors, we assessed the intra- and interindividual 
variability of the selected Raman peaks. The average Raman spectrum of untreated human stratum 
corneum is plotted in figure 9 A (black line). The symbols visualize the calculated mean peak intensities 
+/- standard deviation (SD) of each donor. We observed high variability for each individual donor, but 
no statistically significant difference between the three donors was detected. Furthermore, the 
intraindividual variability was assessed by evaluation of differences between individual samples 
obtained from the same donor. In figure 9 B, the symbols visualize the calculated mean peak 
intensities +/- SD of three samples from donor 1. We observed similar variability, but no significant 
differences between the samples could be noted. Our observations confirm the expected high 
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variability in Raman spectra, but a similar variability between different donors. Thus transferability of 
findings stated by utilizing skin from different individuals is assured. 
 
 
Figure 9: A Inter- and B intraindividual variability of untreated human SC. The symbols represent the 
marked peak area integral +/- SD. A for three different donors (n=9) B for three different samples of 
donor 1 (n=3). No significant differences between samples or donors could be detected. Reproduced 
with permission from (65). 
 
Furthermore, we monitored the variability of the selected peaks upon depth profiling. All peaks 
revealed an increase in relative standard deviation in deeper skin layers. However, the lipid derived 
peak in the spectral range from 1288 cm-1 to 1314 cm-1 exhibited abnormal behavior in a plotted 
intensity depth profile. A steeper decay of the signal intensity compared to peaks of other components 
indicated a concentration gradient of skin lipids. This excluded this specific peak from being suitable 
as internal standard, since a constant signal throughout the depth profile is not given.  
Overall we were able to gain deep understanding of spectral variability of CRM measurements during 
depth profiling in human skin. We confirmed excised human skin as suitable in vitro model and assured 
transferability of results obtained from different donors. Furthermore, our extended knowledge in 
skin depth profiling allowed us to eliminate a candidate peak as potential reference for quantitative 
depth profiling. This proceeds the understanding and overcoming of pitfalls, impeding quantitative 
depth profiling in human skin by CRM. 
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5.4 Quantitative detection of caffeine in human skin by confocal Raman 
spectroscopy – a systematic in vitro validation study 
 
 
This chapter refers to: 
 
L. Franzen, J. Anderski, M. Windbergs, ‘Quantitative detection of caffeine in human skin by confocal 
Raman spectroscopy – a systematic in vitro validation study ‘, Eur J Pharm Biopharm, 95, Part A (2015) 
110-116 
 
 
After elucidating the current limitations for quantitative Raman depth profiling in human skin, the 
newly found knowledge had to be translated into solutions to overcome them. As mentioned earlier, 
the most common way to cope with Raman signal attenuation is the relation of two peaks, resulting 
in relative depth profiles. The intensity of a Raman peak representing the penetrating substance is 
related to a peak representing a skin component. Assuming that both peaks are equally affected by 
signal attenuation, the result is a profile of how deep the substance penetrated into the skin. This peak 
correlation method requires a constant and reliable skin component representing peak as internal 
standard. The objective of this chapter was to validate the approach of peak correlation regarding its 
transferability to quantitative measurements. 
At first, the capability of our instrument to perform quantitative measurements was assured by 
acquisition of spectra in drug solutions of different concentration. A prominent drug representing peak 
was integrated and Raman intensity proved to be linearly related to drug concentration. Furthermore, 
we developed a sample incubation procedure that provided a homogeneous drug concentration 
throughout the whole skin sample. Hence, we expect a constant peak ratio independent of depth for 
each drug concentration. This assures a valid reference to be correlated with our internal skin peak.  
Since the lipid representing peak was already ruled out as internal standard in the previous chapter 
(65), the three aforementioned skin representing peaks were evaluated in terms of suitability as 
internal reference. The C-C stretch vibration represents the ring breathing of aromatic amino acids 
(AAA), detectable in the wavenumber range of 995-1018 cm-1. The unspecific and therefore most 
intense C-H deformation is represented in the wavenumber range 1388-1497 cm-1 and the N-C=O 
stretch vibration embodying amid I, as found in proteins, is detectable in a wavenumber range of 1559-
1721 cm-1 (18).  
We calculated the ratios of the integrated peak intensities of drug and the respective internal skin 
peaks in different sample depths. However, the peak ratios derived from AAA exhibit high divergence 
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even in the upper layers as depicted in figure 10 B. The peak ratios derived from amid I bindings show 
a similar divergence after a depth of 7.5 µm is reached, as illustrated in figure 10 C. Due to high error 
margins and the high variability in deeper tissue layers, both skin peaks cannot provide the expected 
results. These findings impede the utilization of AAA and the amid I vibration as endogenous internal 
standard. 
 
 
Figure 10: A Raman signal intensity of the caffeine representing peak as a function of depth for four 
different caffeine concentrations. B, C, D Ratios of the skin derived peak intensities of B aromatic 
amino acids (AAA), C amid I, D the unspecific C-H vibration and the caffeine representing peak intensity 
as a function of depth for four different caffeine concentrations (mean ± SD, n = 9). Reproduced with 
permission from (66). 
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Fortunately, a correlation of the drug derived peak with the Raman peak representing the unspecific 
C-H deformation features constant values as a function of depth. A horizontal curve progression 
visualizes the constant peak ratio independent from depth for all drug concentrations in figure 10 D. 
To further exploit the C-H / CAF relation we averaged the obtained peak ratios over depth for each 
drug concentration.  After correlating the results with the drug concentration in skin, we achieved an 
excellent accordance of the applied linear fit, as depicted in figure 11. The derived correlation allows 
for converting Raman intensities obtained from skin depth profiling into absolute drug concentration.  
 
 
Figure 11: Ratio of the C-H and caffeine representing peak intensity determined by CRM as a function 
of caffeine concentration per mass stratum corneum determined by HPLC for five different depths 
with applied linear fit (mean ± SD, n = 9). Reproduced with permission from (66). 
 
To conclude this chapter, we finally present a proof-of-concept study that translates the peak 
correlation method to a quantitative measurement setup. We were able to directly relate Raman data 
with actual drug concentrations in human skin in vitro. Based on our previous work this concludes a 
series of investigations focusing on understanding and overcoming the main drawbacks of Raman 
depth profiling. Furthermore, this study serves as another important step towards reliable and 
reproducible quantitative measurements by CRM in human skin in vitro. 
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5.5 Freeze-drying as tailored preparation technique for human skin depth profiling 
by confocal Raman microscopy 
 
 
This chapter refers to: 
 
L. Franzen, L. Vidlarova, K.H. Kostka, U.F. Schaefer, M. Windbergs, ‘Freeze-drying as a preserving 
preparation technique for in vitro testing of human skin’, Exp Dermatol, 22 (2013) 54-56 
 
L. Franzen, J. Anderski, V. Planz, K.H. Kostka, M. Windbergs, ‘Combining confocal Raman microscopy 
and freeze-drying for quantification of substance penetration into human skin‘, Exp Dermatol, 23 
(2014) 942-944 
 
 
To ultimately implement CRM as analytical tool in skin drug delivery research, a reliable and 
standardized setup is necessary. In the previous chapters, we already discussed major pitfalls 
impeding quantitative depth profiling by CRM in human skin in vitro. However, the day-to-day 
measurement routine bares some challenges itself. The combination of conventional sample 
preparation and the advanced analysis by CRM gives way to avoidable uncertainties. During the time-
consuming acquisition of depth profiles, the diffusion of the penetrated substance continues, 
introducing inaccuracies in localization and quantification. Furthermore, the constant exposure to 
laser radiation and the need to operate at air interface, cause drying effects in the excised skin 
samples. This slow drying process can provoke drug crystal growth on the sample surface and leads to 
a shrinking of the sample, which impedes the determination of measurement depth. To conclude, a 
standardized and simplified application of CRM demands a tailored preparation of the in vitro skin 
samples. In this chapter, we present freeze-drying as preserving preparation technique for human skin 
and its application in quantitative CRM depth profiling. 
By freeze-drying an in vitro skin sample after incubation, we transform the skin into a solid matrix. This 
‘mummification’ stops ongoing diffusion, and prevents further drying effects. Based on a 
comprehensive comparison by thermal and spectroscopic analysis, we excluded significant changes in 
structure and composition after freeze-drying. The results of comparing fresh and freeze-dried 
stratum corneum by differential scanning calorimetry (DSC), IR and Raman spectroscopy are depicted 
in figure 12. Moreover, we ruled out the occurrence of drug crystals on the sample surface. This 
comparison confirms the suitability of freeze-drying as preserving preparation technique.  
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Figure 12: A DSC thermograms, B Raman spectra and C IR spectra of stratum corneum before and 
after freeze-drying compared to human skin in vivo. Modified with permission from (67). 
 
In addition, we evaluated freeze-dried skin samples towards their capability to facilitate quantitative 
depth profiling by CRM. After loading skin samples with a defined amount of drug, the drug 
concentration in fresh and freeze-dried samples was determined by HPLC. By a simple correction for 
the weight loss, we were able to determine the original drug concentration in the skin samples prior 
to freeze-drying. The drug concentration in the skin samples as a function of the applied drug amount 
is presented in figure 13 A before and after correction for the weight loss. After acquisition of CRM 
depth profiles, we applied the peak correlation method presented in the previous chapter. Again, we 
were able to establish a linear correlation between Raman signal intensity and drug concentration 
independent from measurement depth, as exhibited in figure 13 B.  
To sum up, freeze-drying of the skin samples after incubation allowed for stopping ongoing diffusion, 
preventing crystal growth and unwanted drying effects. Moreover, we maintain the capability of 
quantitative detection of substances by CRM in freeze-dried samples. This combination of tailored 
sample preparation and advanced data evaluation introduces the necessary simplification and 
standardization for CRM depth profiling. 
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Figure 13: A Concentration of drug in skin determined by HPLC as a function of drug concentration in 
the incubation solution. The drug amount in the freeze- dried skin (blue) was corrected by the weight 
loss (black) to represent the drug amount in fresh skin (red) with applied linear fit (mean ± SD, n = 9). 
B Ratio of the unspecific C-H and drug representing Raman peak intensity as a function of drug 
concentration per mass stratum corneum with applied linear fit (mean ± SD, n = 9). Modified with 
permission from (68). 
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6 Conclusion  
 
Confocal Raman microscopy is an upcoming analytical method in many fields of research. The ability 
for contactless detection and visualization of the chemical sample composition without addition of 
dyes or labels makes CRM a valuable analytical tool. In the course of this thesis, we investigated and 
evaluated different applications of CRM in skin drug delivery research ranging from physiological 
investigations to quantitative depth profiling. We highlighted benefits, exposed limitations and 
overcame drawbacks of confocal Raman microscopy for in vitro analytical tasks related to skin drug 
delivery. 
In the first featured paper, we used confocal Raman imaging to reevaluate the suitability of porcine 
ear skin as in vitro model for analysis of follicular uptake. This study utilizes CRM to gain new valuable 
insights of an established in vitro model and to remove existing doubts. It serves as an example for the 
versatile benefits of an application of CRM in skin drug delivery research. This matches with our first 
initially stated aim. 
Not only for risk assessment of chemicals, but especially for skin drug delivery research, the knowledge 
about rate and extent, with which a substance overcomes the skin barrier is essential. First studies 
already showed the potential of CRM to become a valuable tool for substance follow-up in vitro. 
However, to acquire quantitative information, a linear dependency between signal intensity and 
substance quantity has to be assured during the entire depth profiling process. Raman signal 
attenuation as main drawback reduces the signal intensity inside the skin, causing a loss of the linear 
correlation between Raman signal and substance amount. This issue was addressed in the second 
paper presented in this work. We created an artificial skin surrogate with homogeneous composition 
of the main skin components and were able to assign a mathematical function to the extent of signal 
attenuation. This sophisticated study serves as a first approach to understand and characterize Raman 
signal attenuation. The newly gained knowledge helps to better understand the effect of Raman signal 
attenuation as major drawback in depth profiling and facilitates methods to circumvent it. 
In the third featured paper we addressed arising uncertainties in Raman spectroscopic measurements 
in skin and reviewed the usage of excised female human abdominal skin as standard in vitro model. 
We exposed the expected high but tolerable variability but results gathered from different donors 
varied to a similar extend. This demonstrates that results obtained from different donors are directly 
comparable and a general transferability of the acquired data is given. By investigating the variability 
of excised skin samples, we resolve another major uncertainty in CRM depth profiling, as intended in 
our second aim.  
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The possibility to quantify substance concentration in skin over depth was a missing key feature of 
CRM. Although the potential of CRM for this purpose has been broadly acknowledged, a systematic 
validation study as ultimate proof remained undone. Referencing our extended knowledge from the 
previous works, the fourth presented paper envisaged a proof-of-concept for quantitative depth 
profiling in human skin in vitro, as predetermined in our third aim. 
Numerous previous studies circumvented Raman signal attenuation by relating the drug representing 
peak to a peak representing a skin component. This requires a skin component, which gives a strong 
Raman signal and is equally represented throughout the skin. In the fourth study we approached 
quantitative depth profiling directly by systematically validating multiple skin representing Raman 
peaks towards their suitability as internal standard. This study finally provides a suitable and reliable 
reference peak to broadly establish depth profiling. Furthermore, our systematic proof-of-concept 
study pioneers quantitative measurements in skin by CRM and ultimately overcomes the drawback of 
Raman signal attenuation. 
The novel application of CRM for in vitro depth profiling in human skin also comes with novel demands 
on sample preparation and handling. The time consuming CRM measurements with steady laser 
irradiation afflict the excised human skin and new particular drawbacks arise. During in vitro testing 
these drawbacks like ongoing drug diffusion and changes in the hydration state impede the analysis 
of human skin samples. Meeting our fourth aim, we engaged these drawbacks by establishing a tailor-
made sample preparation method adapted for CRM depth profiling in the featured papers five and 
six. By freeze-drying the skin samples immediately after the penetration experiment and prior to the 
analysis, we conserve the substance localization inside the skin. We ultimately combined freeze-drying 
as tailored sample preparation technique for CRM and quantitative depth profiling. This study finally 
allows the acquisition of quantitative depths profiles without being pressed by time. In combination 
with the previous studies, this work promotes a standardized analytical procedure for substance depth 
profiling. 
In conclusion, we present a comprehensive work addressing the versatile applications of confocal 
Raman microscopy in skin drug delivery research. We present new applications like chemically 
selective 3D imaging of hair follicles and overcome existing limitations like signal attenuation. We 
introduce quantitative depth profiling and offer the combination with freeze-dried skin as further 
development, towards a standardized analytical technique. Overall, this thesis facilitates the basic 
understanding of numerous influencing factors and serves as a first step to establish CRM as analytical 
technique in skin drug delivery research.  
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7 Outlook 
For the near future the possibility of label-free and non-destructive acquisition of concentration depth 
profiles is the most tempting feature of CRM. The progress we made and the hurdles we overcame 
regarding in vitro depth profiling paved the way for future applications. In particular, we present the 
first proof-of-concept for acquisition of quantitative penetration depth profiles and provide an 
analytical model tailor-made for CRM. With this tools CRM can be utilized for quantitative follow-up 
of substances into the skin in vitro, an essential analytical procedure in risk assessment and drug 
delivery research. In a next step the simultaneous tracking of drug and excipient of drug delivery 
systems will become possible. Thus, CRM can not only support researchers in evaluating and 
optimizing drug delivery systems, but also satisfy the increasing demands in pharmacovigilance of 
regulatory agencies like Food and Drug Administration (FDA) and European Medicines Agency (EMA).  
However, further improvements are needed to establish confocal Raman microscopy as standard 
analytical technique in drug delivery laboratories. The simplification of quantitative measurement 
routines and further development of instrumental designs specialized for the desired application are 
necessary. With dedicated software and hardware solutions a variety of affordable and easy-to-handle 
Raman systems is conceivable. Specialized instruments for analysis of skin composition (RiverD®, 
Rotterdam, NL) and skin disease diagnosis (Verisante Aura®, Richmond, BC, CA) are already arriving 
on the market. A Raman apparatus devoted to quantitative in vitro substance follow-up is highly 
anticipated and the presented results might provide key solutions for instrument developers. 
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